Sumgen Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Series C
- Investors
-
18
Sumgen General Information
Description
Developer of innovative antibody drugs designed for the treatment of tumors and other diseases. The company offers computer-aided design combined with mammalian cell display technology to screen and optimize antibody drugs for individual candidates and create effective antibody drugs, thereby enabling patients to receive treatment for major diseases such as cancer.
Contact Information
Website
sumgenbio.comCorporate Office
- 1st Floor, Building C, Number 688 Bin'an Road, Changhe Street
- Binjiang District
- Hangzhou, Zhejiang 310050
- China
Corporate Office
- 1st Floor, Building C, Number 688 Bin'an Road, Changhe Street
- Binjiang District
- Hangzhou, Zhejiang 310050
- China
Sumgen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series C) | 25-Dec-2025 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 06-Dec-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 29-Dec-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 12-Sep-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 31-Mar-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A1) | 01-Jan-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Jun-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 06-Sep-2017 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Mar-2017 | Completed | Clinical Trials - General |
Sumgen Signals
Sumgen Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Qijian Private Equity Fund Management | Growth/Expansion | Minority | ||
| Chime Biologics | VC-Backed Company | Minority | ||
| Oriental Fortune Capital | Venture Capital | Minority | ||
| Shanghai Sitong Private Equity Fund Management | Venture Capital | Minority | ||
| Shenzhen Qianhai Junchuan Investment | Growth/Expansion | Minority |
Sumgen FAQs
-
When was Sumgen founded?
Sumgen was founded in 2015.
-
Where is Sumgen headquartered?
Sumgen is headquartered in Hangzhou, China.
-
What is the size of Sumgen?
Sumgen has 22 total employees.
-
What industry is Sumgen in?
Sumgen’s primary industry is Drug Discovery.
-
Is Sumgen a private or public company?
Sumgen is a Private company.
-
What is Sumgen’s current revenue?
The current revenue for Sumgen is .
-
How much funding has Sumgen raised over time?
Sumgen has raised $71.1M.
-
Who are Sumgen’s investors?
Beijing Qijian Private Equity Fund Management, Chime Biologics, Oriental Fortune Capital, Shanghai Sitong Private Equity Fund Management, and Shenzhen Qianhai Junchuan Investment are 5 of 18 investors who have invested in Sumgen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process